Basic Information
SINGULAIR TABLET 10 mg
TABLET
Regulatory Information
SIN09769P
May 16, 1998
Prescription Only
Therapeutic
ORAL
August 10, 2023
May 30, 2025
XR03DC03
Company Information
ORGANON SINGAPORE PTE. LTD.
ORGANON SINGAPORE PTE. LTD.
Active Ingredients
Strength: 10 mg
Detailed Information
Contraindications
**V. CONTRAINDICATIONS** - Hypersensitivity to any component of this product
Indication Information
**II. INDICATIONS** SINGULAIR is indicated in adult and pediatric patients 1 year of age and older for the prophylaxis and chronic treatment of asthma, including the prevention of day- and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. SINGULAIR is indicated for the relief of daytime and nighttime symptoms of allergic rhinitis (seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older, and perennial allergic rhinitis in adults and pediatric patients 1 year of age and older). Because the benefits of SINGULAIR may not outweigh the risk of neuropsychiatric symptoms in patients with allergic rhinitis, reserve use for patients who have an inadequate response or intolerance to alternative therapies.